Syncom Healthcare Limited
Pharmaceuticals - Bulk Drugs and Formulations BSE:33157 NSE:SYNCOM Bloomberg:SHCL@IN Reuters:SYNH.BO Market Lot: 1 Face Value: 10 ISIN Demat: INE602K01014
Company Announcements
Compliance Certificate For The Period Ended 31St March, 2021
09-JUL-21
Statement Of Investor Complaints For The Quarter Ended 31St March, 2021 Pursuant To Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
08-JUL-21
Statement Of Investor Complaints For The Quarter Ended 31St March, 2021 Pursuant To Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
08-JUL-21
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
08-JUL-21
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
08-JUL-21
Shareholding for the Period Ended March 31, 2021
07-JUL-21
Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
07-JUL-21
Reply To Stock Exchange Query On Approval Of Resolution Plan By NCLT
29-JUN-21
Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal
28-JUN-21
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
28-JUN-21
Board Meeting Intimation for 1. To Consider And Approve The Audited Standalone Financial Results Of The Company For The Fourth Quarter And Year Ended On March 31,2021
28-JUN-21
Announcement under Regulation 30 (LODR)-Newspaper Publication
25-FEB-21
